Around 30% of the patients demonstrate paraneoplastic manifestations such as Cushing syndrome due to adrenocorticotropic hormone (ACTH)-like hormone production (8) and hypercalcemia due to parathyroid hormone-related peptide (PTHrP) production (9). This evidence concerns the gene POMC and Cushing syndrome.